Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + MP vs MP in Elderly Multiple Myeloma
NCT00232934Phase 3Completed
- Sponsor
- Gruppo Italiano per lo Studio del Mieloma Multiplo
- Start
- Jan 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Gruppo Italiano per lo Studio del Mieloma Multiplo. Started Jan 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00232934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232934.